Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial Hypertension
NCT00034307
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
180
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Hypertension
Interventions
DRUG:
sitaxsentan sodium
Sponsor
ICOS-Texas Biotechnology
Collaborators
[object Object]
[object Object]